AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Prestige Consumer Healthcare Inc.
XNYS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001SH44F0
47.80▼ 1.66 (-3.36%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
49.46
Day's Range
47.70 – 49.34
52-Week Range
42.62 – 71.08
Volume
529.4K
Avg Volume
600.7K
Share Statistics
Shares Outstanding
Employees
600
Exchange
XNYS
Listed
2005-02-10
Share count as of July 31, 2026

Prestige Consumer Healthcare Inc. (PBH) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Prestige Consumer Healthcare Inc. (PBH)
What is Prestige Consumer Healthcare Inc.'s Market Cap?
Prestige Consumer Healthcare Inc.'s Market Cap is $2.3B, based on as-reported figures from SEC (XBRL) filings.
What is Prestige Consumer Healthcare Inc.'s Enterprise Value?
Prestige Consumer Healthcare Inc.'s Enterprise Value is $4.2B, based on as-reported figures from SEC (XBRL) filings.
What is Prestige Consumer Healthcare Inc.'s Trailing P/E?
Prestige Consumer Healthcare Inc.'s Trailing P/E is 13.2×, based on as-reported figures from SEC (XBRL) filings.
What is Prestige Consumer Healthcare Inc.'s Price / Sales?
Prestige Consumer Healthcare Inc.'s Price / Sales is 2.0×, based on as-reported figures from SEC (XBRL) filings.
What is Prestige Consumer Healthcare Inc.'s EV / Revenue?
Prestige Consumer Healthcare Inc.'s EV / Revenue is 3.8×, based on as-reported figures from SEC (XBRL) filings.
What is Prestige Consumer Healthcare Inc.'s EV / EBITDA?
Prestige Consumer Healthcare Inc.'s EV / EBITDA is 13.1×, based on as-reported figures from SEC (XBRL) filings.
What is Prestige Consumer Healthcare Inc.'s Revenue (TTM)?
Prestige Consumer Healthcare Inc.'s Revenue (TTM) is $1.1B, based on as-reported figures from SEC (XBRL) filings.
What is Prestige Consumer Healthcare Inc.'s Net Income (TTM)?
Prestige Consumer Healthcare Inc.'s Net Income (TTM) is $172.0M, based on as-reported figures from SEC (XBRL) filings.
What is Prestige Consumer Healthcare Inc.'s EBITDA?
Prestige Consumer Healthcare Inc.'s EBITDA is $322.5M, based on as-reported figures from SEC (XBRL) filings.
What is Prestige Consumer Healthcare Inc.'s Diluted EPS (TTM)?
Prestige Consumer Healthcare Inc.'s Diluted EPS (TTM) is 3.63, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · PBHAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues
Total revenues
YoY growth+6.5%-5.0%-2.4%-3.4%
Cost of Sales
Cost of sales excluding depreciation
Cost of sales depreciation
Cost of sales
Gross profit
% of revenue51.3%51.9%55.5%55.3%
Operating Expenses
Advertising and marketing
General and administrative
Depreciation and amortization
Total operating expenses
% of revenue31.5%25.1%26.4%26.2%
Operating income
% of revenue19.8%26.8%29.1%29.1%
Other expense
Interest expense, net
Other expense (income), net
Total other expense, net
Income before income taxes
Provision for income taxes
Net income
% of revenue11.0%19.1%16.5%15.4%
Basic (in USD per share)
Diluted (in USD per share)